Gastroenterology Medicines

Backed up by our in-house extensive research and clinical precision processes, we offer a trusted range of gastroenterology medicines that are used by a wide base of doctors and pharmaceutical experts. All these medicines are precisely formulated with utmost care and safety that makes them in tune with the global industry accepted standards.

Some of the variants offered in this range are as follows:

Omeprazole /oʊˈmɛprəzoʊl/) is a proton pump inhibitor used in the treatment of dyspepsia, peptic ulcer disease (PUD), gastroesophageal reflux disease (GORD/GERD), laryngopharyngeal reflux (LPR), and Zollinger-Ellison syndrome. Omeprazole is one of the most widely prescribed drugs internationally and is available over the counter in some countries. Prilosec contains the active ingredient omeprazole and Prilosec OTC contains the active ingredient omeprazole magnesium.

Rabeprazole is an antiulcer drug in the class of proton pump inhibitors. It was developed by Eisai Co.

Short-term treatment in healing and symptomatic relief of duodenal ulcers and erosive or ulcerative gastroesophageal reflux disease (GERD); maintaining healing and reducing relapse rates of heartburn symptoms in patients with GERD; treatment of daytime and nighttime heartburn and other symptoms associated with GERD; long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome and in combination with amoxicillin and clarithromycin to eradicate Helicobacter pylori.

• Gastric ulcer
• Peptic ulcer disease (PUD)
• Maintenance of healing of erosive or ulcerative GERD
• Healing of erosive and ulcerative GERD
• Healing of duodenal ulcers.
• Treatment of symptomatic GERD
• Treatment of pathological hypersecretory conditions (Zollinger-Ellison syndrome)
• Helicobacter pylori eradication to reduce risk of duodenal ulcer

Pantoprazole Sodium  is a proton pump inhibitor drug used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease. Initial treatment is generally of eight weeks' duration, after which another eight week course of treatment may be considered if necessary. It can be used as a maintenance therapy for long term use after initial response is obtained. The active ingredient in (pantoprazole sodium) Delayed-Release Tablets is a substituted benzimidazole, sodium 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl] sulfinyl]-1 H -benzimidazole sesquihydrate, a compound that inhibits gastric acid secretion.

Ranitidine hydrochloride (pronounced /r????n??t??di??n/; ) is a histamine H₂-receptor antagonist that inhibits stomach acid production. It is commonly used in treatment of peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD). Certain preparations of ranitidine are available over the counter (OTC) in various countries.

Cimetidine /s????m??t??di??n/, /sa????m??t??di??n/) is a histamine H₂-receptor antagonist that inhibits the production of acid in the stomach. It is largely used in the treatment of heartburn and peptic ulcers.. Cimetidine was approved in the UK in 1976 and was approved in the US by the Food & Drug Administration for prescriptions starting January

200mg, 400 mg

10's,100's,1000's(blister/Bulk)